Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD44 antibody are both extended with the scFv fragment from an anti-CR3 antibody. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Triple Body) (TRIB-121). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS